Administración de ketamina a niños con hipertensión pulmonar
Administration of ketamine to children with pulmonary
hypertension is safe: pro-con debate
PRO ARGUMENT
Glyn D. Williams
Pediatric Anesthesia 22 (2012) 1042-1052
http://onlinelibrary.wiley.com/doi/10.1111/pan.12033/pdf
Epidemiología y manejo clínico de la hipertensión pulmonar en niños
Epidemiology and clinical management of pulmonary hypertension in children.
Jin H, Yang J, Zhang Q, Du J.
Department of Pediatrics, Peking University First Hospital, Beijing, China.
Korean Circ J. 2012 Aug;42(8):513-8. Epub 2012 Aug 31.
Abstract
Pulmonary hypertension (PH) is a clinical hemodynamic syndrome characterized by increased pulmonary artery pressure and pulmonary vascular resistance. It can cause right ventricular failure, and even death. Pediatric PH is not very common, but is a greatly hazardous disease that leads to a high mortality rate. Therefore, many registry organizations have been established in the world to strengthen the study of diagnosis and treatment of the disease, and improve the understanding of pediatric PH. This article reviewed recently published researches, as well as presented a comprehensive understanding of PH, including definition, classification, epidemiology, prognosis and treatment.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438259/pdf/kcj-42-513.pdf
¿Que es la hipertensión pulmonar?
What is pulmonary arterial hypertension? .
Rich S.
Pulm Circ [serial online] 2012 [cited 2012 Oct 12];2:271-2.
Pulmonary arterial hypertension (PAH) is a term that was coined in 1998 at the World Health Organization Symposium on Pulmonary Hypertension at Evian, France. Because a clinically useful classification for pulmonary hypertension was lacking, the late Alfred Fishman proposed a clinical classification system for pulmonary hypertension which has been widely adopted. [1] Its purpose was to provide a guide to physicians who encounter a patient with pulmonary hypertension of uncertain etiology. The classification system helped direct the clinical evaluation of the patient so that underlying disease(s) that might be causing or contributing to the pulmonary hypertension could be identified. PAH (also known as Category 1) includes patients who have an elevation in pulmonary artery pressure with a normal pulmonary wedge pressure, either alone or in association with many other diseases.
http://www.pulmonarycirculation.org/text.asp?2012/2/3/271/101388
Atentamente
Anestesiología y Medicina del Dolor
www.anestesia-dolor.org
Administration of ketamine to children with pulmonary
hypertension is safe: pro-con debate
PRO ARGUMENT
Glyn D. Williams
Pediatric Anesthesia 22 (2012) 1042-1052
http://onlinelibrary.wiley.com/doi/10.1111/pan.12033/pdf
Epidemiología y manejo clínico de la hipertensión pulmonar en niños
Epidemiology and clinical management of pulmonary hypertension in children.
Jin H, Yang J, Zhang Q, Du J.
Department of Pediatrics, Peking University First Hospital, Beijing, China.
Korean Circ J. 2012 Aug;42(8):513-8. Epub 2012 Aug 31.
Abstract
Pulmonary hypertension (PH) is a clinical hemodynamic syndrome characterized by increased pulmonary artery pressure and pulmonary vascular resistance. It can cause right ventricular failure, and even death. Pediatric PH is not very common, but is a greatly hazardous disease that leads to a high mortality rate. Therefore, many registry organizations have been established in the world to strengthen the study of diagnosis and treatment of the disease, and improve the understanding of pediatric PH. This article reviewed recently published researches, as well as presented a comprehensive understanding of PH, including definition, classification, epidemiology, prognosis and treatment.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438259/pdf/kcj-42-513.pdf
¿Que es la hipertensión pulmonar?
What is pulmonary arterial hypertension? .
Rich S.
Pulm Circ [serial online] 2012 [cited 2012 Oct 12];2:271-2.
Pulmonary arterial hypertension (PAH) is a term that was coined in 1998 at the World Health Organization Symposium on Pulmonary Hypertension at Evian, France. Because a clinically useful classification for pulmonary hypertension was lacking, the late Alfred Fishman proposed a clinical classification system for pulmonary hypertension which has been widely adopted. [1] Its purpose was to provide a guide to physicians who encounter a patient with pulmonary hypertension of uncertain etiology. The classification system helped direct the clinical evaluation of the patient so that underlying disease(s) that might be causing or contributing to the pulmonary hypertension could be identified. PAH (also known as Category 1) includes patients who have an elevation in pulmonary artery pressure with a normal pulmonary wedge pressure, either alone or in association with many other diseases.
http://www.pulmonarycirculation.org/text.asp?2012/2/3/271/101388
Atentamente
Anestesiología y Medicina del Dolor
www.anestesia-dolor.org
No hay comentarios:
Publicar un comentario